abstract “use of shroom 3 in chronic kidney disease and chronic allograft nephropathy” method of identifying the risk of developing chronic allograft nephropathy (can) in patients receiving donor kidney transplantation, which includes the identification of donor ethnicity ; determination of shroom 3 expression levels in a kidney biopsy specimen obtained from the patient at a predetermined time after transplantation; comparison of shroom 3 expression level in the biopsy sample with shroom 3 expression levels in one control; Determination if the shroom 3 expression level in the graft is significantly higher than in the control and diagnosis of the at-risk patient if the shroom 3 expression level in the sample is significantly higher than in the control.
展开▼
